aluates Reports

$ 0.0

Automative

Global Bronchiectasis Treatment Drug Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-14Q14465

Global Bronchiectasis Treatment Drug Market Research Report 2023

BUY CHAPTERS

Global Bronchiectasis Treatment Drug Market Research Report 2025

Code: QYRE-Auto-14Q14465

Report

March 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Grifols S A

GlaxoSmithKline PLC

Sanofi

Boehringer Ingelheim

Aradigm Corporation

Zambon

Santhera Pharmaceuticals

Bayer

Insmed

Alitair Pharmaceuticals

Polyphor

Kamada

Cadilapharma

Bronchiectasis Treatment Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Bronchiectasis Treatment Drug Market

The global market for Bronchiectasis Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Bronchiectasis Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bronchiectasis Treatment Drug.

The Bronchiectasis Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bronchiectasis Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bronchiectasis Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bronchiectasis Treatment Drug Market Report

Report Metric	Details
Report Name	Bronchiectasis Treatment Drug Market
CAGR	5%
Segment by Type	Amikacin Sulfate ARD-3150 CHF-6333 Ciprofloxacin Hydrochloride Doxofylline Others
Segment by Application	Offline Pharmacy Online Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Grifols, GlaxoSmithKline, Sanofi, Boehringer-Ingelheim, Cadilapharma, Aradigm Corporation, Zambon, Santhera Pharmaceuticals, Bayer, Insmed Inc, Alitair Pharmaceuticals, Polyphor, Kamada Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bronchiectasis Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bronchiectasis Treatment Drug Market report?

Ans: The main players in the Bronchiectasis Treatment Drug Market are Grifols, GlaxoSmithKline, Sanofi, Boehringer-Ingelheim, Cadilapharma, Aradigm Corporation, Zambon, Santhera Pharmaceuticals, Bayer, Insmed Inc, Alitair Pharmaceuticals, Polyphor, Kamada Ltd

What are the Application segmentation covered in the Bronchiectasis Treatment Drug Market report?

Ans: The Applications covered in the Bronchiectasis Treatment Drug Market report are Offline Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Bronchiectasis Treatment Drug Market report?

Ans: The Types covered in the Bronchiectasis Treatment Drug Market report are Amikacin Sulfate, ARD-3150, CHF-6333, Ciprofloxacin Hydrochloride, Doxofylline, Others

Recommended Reports

Respiratory Drug Markets

Asthma And Bronchial

Lung Disease Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bronchiectasis Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Amikacin Sulfate

1.2.3 ARD-3150

1.2.4 CHF-6333

1.2.5 Ciprofloxacin Hydrochloride

1.2.6 Doxofylline

1.2.7 Others

1.3 Market by Application

1.3.1 Global Bronchiectasis Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Offline Pharmacy

1.3.3 Online Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Bronchiectasis Treatment Drug Market Perspective (2020-2031)

2.2 Global Bronchiectasis Treatment Drug Growth Trends by Region

2.2.1 Global Bronchiectasis Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Bronchiectasis Treatment Drug Historic Market Size by Region (2020-2025)

2.2.3 Bronchiectasis Treatment Drug Forecasted Market Size by Region (2026-2031)

2.3 Bronchiectasis Treatment Drug Market Dynamics

2.3.1 Bronchiectasis Treatment Drug Industry Trends

2.3.2 Bronchiectasis Treatment Drug Market Drivers

2.3.3 Bronchiectasis Treatment Drug Market Challenges

2.3.4 Bronchiectasis Treatment Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Bronchiectasis Treatment Drug Players by Revenue

3.1.1 Global Top Bronchiectasis Treatment Drug Players by Revenue (2020-2025)

3.1.2 Global Bronchiectasis Treatment Drug Revenue Market Share by Players (2020-2025)

3.2 Global Bronchiectasis Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Bronchiectasis Treatment Drug Revenue

3.4 Global Bronchiectasis Treatment Drug Market Concentration Ratio

3.4.1 Global Bronchiectasis Treatment Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Treatment Drug Revenue in 2024

3.5 Global Key Players of Bronchiectasis Treatment Drug Head office and Area Served

3.6 Global Key Players of Bronchiectasis Treatment Drug, Product and Application

3.7 Global Key Players of Bronchiectasis Treatment Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Bronchiectasis Treatment Drug Breakdown Data by Type

4.1 Global Bronchiectasis Treatment Drug Historic Market Size by Type (2020-2025)

4.2 Global Bronchiectasis Treatment Drug Forecasted Market Size by Type (2026-2031)

5 Bronchiectasis Treatment Drug Breakdown Data by Application

5.1 Global Bronchiectasis Treatment Drug Historic Market Size by Application (2020-2025)

5.2 Global Bronchiectasis Treatment Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Bronchiectasis Treatment Drug Market Size (2020-2031)

6.2 North America Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Bronchiectasis Treatment Drug Market Size by Country (2020-2025)

6.4 North America Bronchiectasis Treatment Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Bronchiectasis Treatment Drug Market Size (2020-2031)

7.2 Europe Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Bronchiectasis Treatment Drug Market Size by Country (2020-2025)

7.4 Europe Bronchiectasis Treatment Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Bronchiectasis Treatment Drug Market Size (2020-2031)

8.2 Asia-Pacific Bronchiectasis Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Bronchiectasis Treatment Drug Market Size (2020-2031)

9.2 Latin America Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Bronchiectasis Treatment Drug Market Size by Country (2020-2025)

9.4 Latin America Bronchiectasis Treatment Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Bronchiectasis Treatment Drug Market Size (2020-2031)

10.2 Middle East & Africa Bronchiectasis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Grifols

11.1.1 Grifols Company Details

11.1.2 Grifols Business Overview

11.1.3 Grifols Bronchiectasis Treatment Drug Introduction

11.1.4 Grifols Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.1.5 Grifols Recent Development

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Details

11.2.2 GlaxoSmithKline Business Overview

11.2.3 GlaxoSmithKline Bronchiectasis Treatment Drug Introduction

11.2.4 GlaxoSmithKline Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.2.5 GlaxoSmithKline Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Bronchiectasis Treatment Drug Introduction

11.3.4 Sanofi Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.3.5 Sanofi Recent Development

11.4 Boehringer-Ingelheim

11.4.1 Boehringer-Ingelheim Company Details

11.4.2 Boehringer-Ingelheim Business Overview

11.4.3 Boehringer-Ingelheim Bronchiectasis Treatment Drug Introduction

11.4.4 Boehringer-Ingelheim Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.4.5 Boehringer-Ingelheim Recent Development

11.5 Cadilapharma

11.5.1 Cadilapharma Company Details

11.5.2 Cadilapharma Business Overview

11.5.3 Cadilapharma Bronchiectasis Treatment Drug Introduction

11.5.4 Cadilapharma Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.5.5 Cadilapharma Recent Development

11.6 Aradigm Corporation

11.6.1 Aradigm Corporation Company Details

11.6.2 Aradigm Corporation Business Overview

11.6.3 Aradigm Corporation Bronchiectasis Treatment Drug Introduction

11.6.4 Aradigm Corporation Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.6.5 Aradigm Corporation Recent Development

11.7 Zambon

11.7.1 Zambon Company Details

11.7.2 Zambon Business Overview

11.7.3 Zambon Bronchiectasis Treatment Drug Introduction

11.7.4 Zambon Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.7.5 Zambon Recent Development

11.8 Santhera Pharmaceuticals

11.8.1 Santhera Pharmaceuticals Company Details

11.8.2 Santhera Pharmaceuticals Business Overview

11.8.3 Santhera Pharmaceuticals Bronchiectasis Treatment Drug Introduction

11.8.4 Santhera Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.8.5 Santhera Pharmaceuticals Recent Development

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Bronchiectasis Treatment Drug Introduction

11.9.4 Bayer Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.9.5 Bayer Recent Development

11.10 Insmed Inc

11.10.1 Insmed Inc Company Details

11.10.2 Insmed Inc Business Overview

11.10.3 Insmed Inc Bronchiectasis Treatment Drug Introduction

11.10.4 Insmed Inc Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.10.5 Insmed Inc Recent Development

11.11 Alitair Pharmaceuticals

11.11.1 Alitair Pharmaceuticals Company Details

11.11.2 Alitair Pharmaceuticals Business Overview

11.11.3 Alitair Pharmaceuticals Bronchiectasis Treatment Drug Introduction

11.11.4 Alitair Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.11.5 Alitair Pharmaceuticals Recent Development

11.12 Polyphor

11.12.1 Polyphor Company Details

11.12.2 Polyphor Business Overview

11.12.3 Polyphor Bronchiectasis Treatment Drug Introduction

11.12.4 Polyphor Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.12.5 Polyphor Recent Development

11.13 Kamada Ltd

11.13.1 Kamada Ltd Company Details

11.13.2 Kamada Ltd Business Overview

11.13.3 Kamada Ltd Bronchiectasis Treatment Drug Introduction

11.13.4 Kamada Ltd Revenue in Bronchiectasis Treatment Drug Business (2020-2025)

11.13.5 Kamada Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Grifols S A

GlaxoSmithKline PLC

Sanofi

Boehringer Ingelheim

Aradigm Corporation

Zambon

Santhera Pharmaceuticals

Bayer

Insmed

Alitair Pharmaceuticals

Polyphor

Kamada

Cadilapharma

List of Tables

Table 1. Global Bronchiectasis Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Amikacin Sulfate

Table 3. Key Players of ARD-3150

Table 4. Key Players of CHF-6333

Table 5. Key Players of Ciprofloxacin Hydrochloride

Table 6. Key Players of Doxofylline

Table 7. Key Players of Others

Table 8. Global Bronchiectasis Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Bronchiectasis Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Bronchiectasis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Bronchiectasis Treatment Drug Market Share by Region (2020-2025)

Table 12. Global Bronchiectasis Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Bronchiectasis Treatment Drug Market Share by Region (2026-2031)

Table 14. Bronchiectasis Treatment Drug Market Trends

Table 15. Bronchiectasis Treatment Drug Market Drivers

Table 16. Bronchiectasis Treatment Drug Market Challenges

Table 17. Bronchiectasis Treatment Drug Market Restraints

Table 18. Global Bronchiectasis Treatment Drug Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Bronchiectasis Treatment Drug Market Share by Players (2020-2025)

Table 20. Global Top Bronchiectasis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Treatment Drug as of 2024)

Table 21. Ranking of Global Top Bronchiectasis Treatment Drug Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Bronchiectasis Treatment Drug Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Bronchiectasis Treatment Drug, Headquarters and Area Served

Table 24. Global Key Players of Bronchiectasis Treatment Drug, Product and Application

Table 25. Global Key Players of Bronchiectasis Treatment Drug, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Bronchiectasis Treatment Drug Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Bronchiectasis Treatment Drug Revenue Market Share by Type (2020-2025)

Table 29. Global Bronchiectasis Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Bronchiectasis Treatment Drug Revenue Market Share by Type (2026-2031)

Table 31. Global Bronchiectasis Treatment Drug Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Bronchiectasis Treatment Drug Revenue Market Share by Application (2020-2025)

Table 33. Global Bronchiectasis Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Bronchiectasis Treatment Drug Revenue Market Share by Application (2026-2031)

Table 35. North America Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Bronchiectasis Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Bronchiectasis Treatment Drug Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Bronchiectasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Bronchiectasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 50. Grifols Company Details

Table 51. Grifols Business Overview

Table 52. Grifols Bronchiectasis Treatment Drug Product

Table 53. Grifols Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 54. Grifols Recent Development

Table 55. GlaxoSmithKline Company Details

Table 56. GlaxoSmithKline Business Overview

Table 57. GlaxoSmithKline Bronchiectasis Treatment Drug Product

Table 58. GlaxoSmithKline Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 59. GlaxoSmithKline Recent Development

Table 60. Sanofi Company Details

Table 61. Sanofi Business Overview

Table 62. Sanofi Bronchiectasis Treatment Drug Product

Table 63. Sanofi Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 64. Sanofi Recent Development

Table 65. Boehringer-Ingelheim Company Details

Table 66. Boehringer-Ingelheim Business Overview

Table 67. Boehringer-Ingelheim Bronchiectasis Treatment Drug Product

Table 68. Boehringer-Ingelheim Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 69. Boehringer-Ingelheim Recent Development

Table 70. Cadilapharma Company Details

Table 71. Cadilapharma Business Overview

Table 72. Cadilapharma Bronchiectasis Treatment Drug Product

Table 73. Cadilapharma Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 74. Cadilapharma Recent Development

Table 75. Aradigm Corporation Company Details

Table 76. Aradigm Corporation Business Overview

Table 77. Aradigm Corporation Bronchiectasis Treatment Drug Product

Table 78. Aradigm Corporation Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 79. Aradigm Corporation Recent Development

Table 80. Zambon Company Details

Table 81. Zambon Business Overview

Table 82. Zambon Bronchiectasis Treatment Drug Product

Table 83. Zambon Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 84. Zambon Recent Development

Table 85. Santhera Pharmaceuticals Company Details

Table 86. Santhera Pharmaceuticals Business Overview

Table 87. Santhera Pharmaceuticals Bronchiectasis Treatment Drug Product

Table 88. Santhera Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 89. Santhera Pharmaceuticals Recent Development

Table 90. Bayer Company Details

Table 91. Bayer Business Overview

Table 92. Bayer Bronchiectasis Treatment Drug Product

Table 93. Bayer Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 94. Bayer Recent Development

Table 95. Insmed Inc Company Details

Table 96. Insmed Inc Business Overview

Table 97. Insmed Inc Bronchiectasis Treatment Drug Product

Table 98. Insmed Inc Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 99. Insmed Inc Recent Development

Table 100. Alitair Pharmaceuticals Company Details

Table 101. Alitair Pharmaceuticals Business Overview

Table 102. Alitair Pharmaceuticals Bronchiectasis Treatment Drug Product

Table 103. Alitair Pharmaceuticals Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 104. Alitair Pharmaceuticals Recent Development

Table 105. Polyphor Company Details

Table 106. Polyphor Business Overview

Table 107. Polyphor Bronchiectasis Treatment Drug Product

Table 108. Polyphor Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 109. Polyphor Recent Development

Table 110. Kamada Ltd Company Details

Table 111. Kamada Ltd Business Overview

Table 112. Kamada Ltd Bronchiectasis Treatment Drug Product

Table 113. Kamada Ltd Revenue in Bronchiectasis Treatment Drug Business (2020-2025) & (US$ Million)

Table 114. Kamada Ltd Recent Development

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

Table 118. Authors List of This Report

List of Figures

Figure 1. Bronchiectasis Treatment Drug Picture

Figure 2. Global Bronchiectasis Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bronchiectasis Treatment Drug Market Share by Type: 2024 VS 2031

Figure 4. Amikacin Sulfate Features

Figure 5. ARD-3150 Features

Figure 6. CHF-6333 Features

Figure 7. Ciprofloxacin Hydrochloride Features

Figure 8. Doxofylline Features

Figure 9. Others Features

Figure 10. Global Bronchiectasis Treatment Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Bronchiectasis Treatment Drug Market Share by Application: 2024 VS 2031

Figure 12. Offline Pharmacy Case Studies

Figure 13. Online Pharmacy Case Studies

Figure 14. Bronchiectasis Treatment Drug Report Years Considered

Figure 15. Global Bronchiectasis Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Bronchiectasis Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Bronchiectasis Treatment Drug Market Share by Region: 2024 VS 2031

Figure 18. Global Bronchiectasis Treatment Drug Market Share by Players in 2024

Figure 19. Global Top Bronchiectasis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchiectasis Treatment Drug as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Bronchiectasis Treatment Drug Revenue in 2024

Figure 21. North America Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Bronchiectasis Treatment Drug Market Share by Country (2020-2031)

Figure 23. United States Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Bronchiectasis Treatment Drug Market Share by Country (2020-2031)

Figure 27. Germany Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Bronchiectasis Treatment Drug Market Share by Region (2020-2031)

Figure 35. China Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Bronchiectasis Treatment Drug Market Share by Country (2020-2031)

Figure 43. Mexico Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Bronchiectasis Treatment Drug Market Share by Country (2020-2031)

Figure 47. Turkey Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Bronchiectasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Grifols Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 51. GlaxoSmithKline Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 52. Sanofi Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 53. Boehringer-Ingelheim Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 54. Cadilapharma Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 55. Aradigm Corporation Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 56. Zambon Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 57. Santhera Pharmaceuticals Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 58. Bayer Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 59. Insmed Inc Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 60. Alitair Pharmaceuticals Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 61. Polyphor Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 62. Kamada Ltd Revenue Growth Rate in Bronchiectasis Treatment Drug Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Research Report 2025

Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Obstructive Pulmonary Disease Clinical Therapeutics Market Research Report 2025

Global Chronic Obstructive Pulmonary Disease Therapeutics Market Research Report 2024

Lung Disease Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cystic Fibrosis Therapeutics Market Research Report 2025

Lung Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bronchiectasis Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bronchitis Treatment Drug Market Research Report 2025

Global Bronchitis Drug Market Research Report 2024

Global Therapeutic Bronchoscope Market Research Report 2024

Global Aerosol Bronchodilator Market Research Report 2025

Babesiosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cystic Fibrosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Asthma Therapeutic Drug Market Research Report 2024

Global Asthma Clinical Therapeutic Drug Market Research Report 2025

Global Bronchopulmonary Dysplasia Drug Market Research Report 2024

RELATED REPORTS

Global Asthma Monitoring Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5Y16546

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Respiratory Disease Test Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2Q16721

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Breath-activated Dry Powder Inhaler Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28Z16251

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Respiratory System Chronic Disease Inhalation Preparation Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24R16205

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions